Shuo Liu

1.5k total citations
33 papers, 1.1k citations indexed

About

Shuo Liu is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Shuo Liu has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 14 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Shuo Liu's work include interferon and immune responses (10 papers), Immune Response and Inflammation (6 papers) and Cancer-related molecular mechanisms research (6 papers). Shuo Liu is often cited by papers focused on interferon and immune responses (10 papers), Immune Response and Inflammation (6 papers) and Cancer-related molecular mechanisms research (6 papers). Shuo Liu collaborates with scholars based in China, United States and United Kingdom. Shuo Liu's co-authors include Xuetao Cao, Minghong Jiang, Yuanwu Ma, Lianfeng Zhang, Lun Liu, Zongheng Yang, Wendie Wang, Wei Liu, Shikun Zhang and Hongyu Lin and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Shuo Liu

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuo Liu China 16 628 561 407 113 97 33 1.1k
Haixu Xu China 18 504 0.8× 158 0.3× 349 0.9× 310 2.7× 91 0.9× 43 1.0k
Tianhao Duan United States 10 509 0.8× 586 1.0× 112 0.3× 237 2.1× 152 1.6× 13 1.2k
Kotaro Kiga Japan 18 945 1.5× 275 0.5× 478 1.2× 196 1.7× 74 0.8× 40 1.6k
Enrique Boccardo Brazil 24 676 1.1× 291 0.5× 418 1.0× 447 4.0× 319 3.3× 54 1.4k
Tian Sun China 15 566 0.9× 276 0.5× 97 0.2× 97 0.9× 102 1.1× 30 1.0k
Guanghui Yi China 16 581 0.9× 781 1.4× 141 0.3× 156 1.4× 99 1.0× 31 1.3k
Saskia F. Erttmann Sweden 10 588 0.9× 534 1.0× 94 0.2× 131 1.2× 172 1.8× 17 1.1k
Dafei Chai China 17 562 0.9× 432 0.8× 102 0.3× 155 1.4× 343 3.5× 56 1.4k
István Balázs Németh Hungary 17 326 0.5× 175 0.3× 177 0.4× 155 1.4× 187 1.9× 70 958
Xiangguo Duan China 14 258 0.4× 323 0.6× 127 0.3× 87 0.8× 186 1.9× 36 719

Countries citing papers authored by Shuo Liu

Since Specialization
Citations

This map shows the geographic impact of Shuo Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuo Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuo Liu more than expected).

Fields of papers citing papers by Shuo Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuo Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuo Liu. The network helps show where Shuo Liu may publish in the future.

Co-authorship network of co-authors of Shuo Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuo Liu. A scholar is included among the top collaborators of Shuo Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuo Liu. Shuo Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Jian, Sanpeng Xu, Zhiqing Li, et al.. (2025). SARS-CoV-2 enhances complement-mediated endothelial injury via the suppression of membrane complement regulatory proteins. Emerging Microbes & Infections. 14(1). 2467781–2467781. 1 indexed citations
2.
Zhang, Yaxin, Shuo Liu, Cheng Peng, et al.. (2025). Pathogenicity of Novel H3 Avian Influenza Viruses in Chickens and Development of a Promising Vaccine. Viruses. 17(3). 288–288.
3.
Yang, Zongheng, Lun Liu, Shuo Liu, et al.. (2024). Promotion of TLR7-MyD88-dependent inflammation and autoimmunity in mice through stem-loop changes in Lnc-Atg16l1. Nature Communications. 15(1). 10224–10224. 6 indexed citations
4.
Liu, Wei, Yuyang Wang, Shuo Liu, et al.. (2024). E3 Ubiquitin Ligase RNF13 Suppresses TLR Lysosomal Degradation by Promoting LAMP‐1 Proteasomal Degradation. Advanced Science. 11(32). e2309560–e2309560. 7 indexed citations
6.
Liu, Shuo, Wenbo Zhang, Yujia Wang, et al.. (2023). Pharmacological inhibition of MYC to mitigate chemoresistance in preclinical models of squamous cell carcinoma. Theranostics. 14(2). 622–639. 14 indexed citations
7.
Liu, Juan, Ha Zhu, Yujia Wang, et al.. (2022). lncRNA-GM targets Foxo1 to promote T cell–mediated autoimmunity. Science Advances. 8(31). eabn9181–eabn9181. 15 indexed citations
8.
Liu, Shuo, et al.. (2022). Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma. OncoImmunology. 11(1). 2130583–2130583. 11 indexed citations
9.
Liu, Shuo, et al.. (2022). Bacteria-like tumor vaccines progressively initiate cascade reaction for precise antigen delivery and induction of anti-tumor cellular immune response. Chemical Engineering Journal. 450. 138136–138136. 5 indexed citations
10.
Liu, Shuo, Jiaqi Liu, Xue Yang, et al.. (2021). Cis -acting lnc-Cxcl2 restrains neutrophil-mediated lung inflammation by inhibiting epithelial cell CXCL2 expression in virus infection. Proceedings of the National Academy of Sciences. 118(41). 33 indexed citations
11.
Wang, Yun, Ling Yang, Shuo Liu, et al.. (2021). Improvement in phenotype homeostasis of macrophages by chitosan nanoparticles and subsequent impacts on liver injury and tumor treatment. Carbohydrate Polymers. 277. 118891–118891. 25 indexed citations
12.
Liu, Shuo, et al.. (2020). Bioinformatics Gene Analysis of Potential Biomarkers and Therapeutic Targets for Unstable Atherosclerotic Plaque-Related Stroke. Journal of Molecular Neuroscience. 71(5). 1031–1045. 18 indexed citations
13.
14.
Liu, Shuo, Jun Li, Teng Wang, et al.. (2019). Illumination of cell cycle progression by multi-fluorescent sensing system. Cell Cycle. 18(12). 1364–1378. 2 indexed citations
15.
Lin, Hongyu, Minghong Jiang, Lun Liu, et al.. (2019). The long noncoding RNA Lnczc3h7a promotes a TRIM25-mediated RIG-I antiviral innate immune response. Nature Immunology. 20(7). 812–823. 143 indexed citations
16.
Han, Zhen, Shuo Liu, Hongsheng Lin, et al.. (2019). Inhibition of murine hepatoma tumor growth by cryptotanshinone involves TLR7-dependent activation of macrophages and induction of adaptive antitumor immune defenses. Cancer Immunology Immunotherapy. 68(7). 1073–1085. 56 indexed citations
17.
Yan, Fangfang, Shuo Liu, Along Gao, et al.. (2019). Complement C1q subunit molecules from Xenopus laevis possess conserved function in C1q-immunoglobulin interaction. Developmental & Comparative Immunology. 103. 103532–103532. 10 indexed citations
18.
Liu, Shuo, et al.. (2019). E3 ubiquitin ligase RNF170 inhibits innate immune responses by targeting and degrading TLR3 in murine cells. Cellular and Molecular Immunology. 17(8). 865–874. 18 indexed citations
19.
Liu, Shuo, Minghong Jiang, Wendie Wang, et al.. (2017). Nuclear RNF2 inhibits interferon function by promoting K33-linked STAT1 disassociation from DNA. Nature Immunology. 19(1). 41–52. 58 indexed citations
20.
Liu, Shuo, et al.. (2016). Crytotanshinone Induces the Maturation of Human Dendritic Cells through Activation of NF-kB, p38 and JNK MAPKs. The Journal of Immunology. 196(1_Supplement). 142.20–142.20. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026